Unlike in the rest of the country, where intestinal ultrasound rarely is used in the clinic, in New York City, gastroenterologists at Mount Sinai Hospital have made IUS findings the “the fifth vital sign” for inflammatory bowel disease patient care, particularly to monitor disease. Now, new research from the institution and other centers is showing that the tool can identify patients with endoscopic recurrence and possibly predict disease outcomes and treatment response.
Trending
- U.S. FDA Grants Full Approval to Pfizer’s BRAFTOVI Combination Regimen in First-Line Metastatic Colorectal Cancer (Pfizer)
- Oshi Health’s 2025 Impact Report Demonstrates Exceptional GI Outcomes and Cost Savings at Scale (PR Newswire)
- Medtronic announces CE Mark for the next generation GI Genius™ module and ColonPRO™ software (Medtronic)
- Allurion gets FDA nod for weight loss balloon (Mass Device)
- The 7 Must-Haves For The Doctor Of the 21st Century (The Medical Futurist)
- Will AI Eventually De-Skill Doctors? The Evidence Is Trickling In (Forbes)
- CRC Screening by Colonoscopy and FIT Improves Early Detection over Usual Care (Inside Precision Medicine)
- It’s Called the ‘Fitbit for Farts’—and It’s No Joke (The Wall Street Journal)
